Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedMar 25, 2025
DataAggregated Company Financials
Companies53
  • 7D-0.7%
  • 3M7.1%
  • 1Y3.2%
  • YTD7.3%

The Pharma industry is up 1.3% in the last week, with Caliway Biopharmaceuticals up 2.9%. In the last 12 months, the industry was up 4.5%. Earnings are forecast to grow by 58% annually.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 25 Mar 2025NT$648.6bNT$112.8bNT$10.9b19.7x59.7x5.7x
Thu, 20 Feb 2025NT$672.5bNT$109.3bNT$11.5b23.3x58.5x6.2x
Sat, 18 Jan 2025NT$599.8bNT$109.3bNT$11.4b21.1x52.5x5.5x
Mon, 16 Dec 2024NT$583.4bNT$109.3bNT$11.4b21.9x51x5.3x
Wed, 13 Nov 2024NT$630.5bNT$105.5bNT$9.6b24.9x65.7x6x
Fri, 11 Oct 2024NT$627.1bNT$104.7bNT$8.9b27.1x70.1x6x
Sun, 08 Sep 2024NT$630.2bNT$104.7bNT$8.9b25.7x70.5x6x
Tue, 06 Aug 2024NT$594.0bNT$100.5bNT$6.8b26.9x87x5.9x
Thu, 04 Jul 2024NT$713.9bNT$100.5bNT$6.8b32.4x104.6x7.1x
Sat, 01 Jun 2024NT$625.0bNT$100.4bNT$7.1b29.5x87.5x6.2x
Mon, 29 Apr 2024NT$621.0bNT$101.8bNT$9.4b25.4x66.4x6.1x
Wed, 27 Mar 2024NT$630.3bNT$101.1bNT$9.5b26.1x66.7x6.2x
Fri, 23 Feb 2024NT$642.8bNT$101.6bNT$8.2b24.1x78.8x6.3x
Sun, 21 Jan 2024NT$589.0bNT$101.9bNT$7.8b24.2x75.6x5.8x
Tue, 19 Dec 2023NT$587.4bNT$101.6bNT$7.6b24.7x77x5.8x
Thu, 16 Nov 2023NT$559.7bNT$101.6bNT$8.9b21.6x62.6x5.5x
Sat, 14 Oct 2023NT$536.6bNT$101.7bNT$9.6b20.9x55.8x5.3x
Mon, 11 Sep 2023NT$547.8bNT$101.7bNT$9.6b22.4x56.9x5.4x
Wed, 09 Aug 2023NT$569.3bNT$98.5bNT$10.0b16.7x57.2x5.8x
Fri, 07 Jul 2023NT$590.9bNT$98.7bNT$10.1b17.1x58.7x6x
Sun, 04 Jun 2023NT$580.9bNT$97.8bNT$11.0b16.8x52.7x5.9x
Tue, 02 May 2023NT$569.0bNT$92.1bNT$8.6b22.5x66.3x6.2x
Thu, 30 Mar 2023NT$573.3bNT$91.2bNT$8.0b20.2x71.6x6.3x
Sat, 25 Feb 2023NT$559.2bNT$84.7bNT$7.6b23.6x73.1x6.6x
Mon, 23 Jan 2023NT$484.3bNT$84.6bNT$7.9b20.6x61.4x5.7x
Wed, 21 Dec 2022NT$475.7bNT$84.6bNT$7.9b22.1x60.3x5.6x
Fri, 18 Nov 2022NT$440.7bNT$84.4bNT$8.5b15.7x51.6x5.2x
Sun, 16 Oct 2022NT$416.2bNT$78.9bNT$4.3b17x96.2x5.3x
Tue, 13 Sep 2022NT$470.1bNT$78.9bNT$4.3b18.5x108.6x6x
Thu, 11 Aug 2022NT$388.2bNT$77.2bNT$4.8b20.1x80.6x5x
Sat, 09 Jul 2022NT$379.8bNT$76.8bNT$4.4b21.8x86.9x4.9x
Mon, 06 Jun 2022NT$374.8bNT$76.8bNT$4.4b20.1x85.8x4.9x
Wed, 04 May 2022NT$390.2bNT$76.6bNT$6.6b21.4x59.6x5.1x
Fri, 01 Apr 2022NT$404.0bNT$76.5bNT$6.6b20.6x61.2x5.3x
Price to Earnings Ratio

61.2x


Total Market Cap: NT$404.0bTotal Earnings: NT$6.6bTotal Revenue: NT$76.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 71.2x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 60.1x which is lower than its 3-year average PE of 71.2x.
  • The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 7.5% per year over the last three years.
  • Revenues for these companies have grown 14% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-0.05%
Healthcare-0.15%
Pharma-0.72%
Pharma-0.72%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6936 Vetnostrum Animal HealthNT$47.3018.1%
+NT$480.6m		26.3%n/a
4166 Orient PharmaNT$36.953.8%
+NT$301.1m		82.9%PE69.2x
4746 Formosa LaboratoriesNT$73.602.2%
+NT$192.4m		-28.9%PE56.3x
6838 Formosa PharmaceuticalsNT$32.303.2%
+NT$151.0m		-39.4%PS34x
4167 Savior LifetecNT$20.802.2%
+NT$142.8m		8.9%PE36.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4746

NT$73.60

Formosa Laboratories

7D

2.2%

1Y

-28.9%

Formosa Laboratories' (TWSE:4746) Strong Earnings Are Of Good Quality

Mar 23
Formosa Laboratories' (TWSE:4746) Strong Earnings Are Of Good Quality

1734

NT$31.90

Sinphar PharmaceuticalLtd

7D

0.8%

1Y

-3.2%

1762

NT$33.50

Chunghwa Chemical Synthesis & Biotech

7D

2.1%

1Y

-31.8%

4743

NT$72.20

Oneness Biotech

7D

-3.9%

1Y

-55.7%

7754

NT$22.90

AnnJi Pharmaceutical

7D

-18.5%

1Y

n/a

1795

NT$252.50

Lotus Pharmaceutical

7D

-1.6%

1Y

-13.8%

6472

NT$780.00

Bora Pharmaceuticals

7D

0.1%

1Y

25.8%

6838

NT$32.30

Formosa Pharmaceuticals

7D

3.2%

1Y

-39.4%

6467

NT$78.50

Taho Pharmaceuticals

7D

-10.1%

1Y

n/a

6535

NT$205.50

Lumosa Therapeutics

7D

-1.9%

1Y

14.2%

7759

NT$159.50

Sunhawk Vision Biotech

7D

-12.4%

1Y

n/a

6936

NT$47.30

Vetnostrum Animal Health

7D

18.1%

1Y

26.3%

4167

NT$20.80

Savior Lifetec

7D

2.2%

1Y

8.9%

6620

NT$87.30

Handa Pharmaceuticals

7D

-3.0%

1Y

-46.4%

4166

NT$36.95

Orient Pharma

7D

3.8%

1Y

82.9%

6919

NT$894.00

Caliway Biopharmaceuticals

7D

-0.4%

1Y

269.0%